Vianex S.A.

Vianex S.A.

VIANEX S.A. Factory D in the Industrial zone of Patras
Company type	Incorporated
Industry	Pharmaceutical
Founded	1971
Founder	Pavlos Giannakopoulos Thanasis Giannakopoulos Kostas Giannakopoulos
Headquarters	Athens, Greece
Area served	Worldwide
Key people	Dimitrios Giannakopoulos (Chairman & CEO)
Revenue	€236.31 million (2017)[1]
Operating income	€45.041 million (2017)[2]
Net income	€4.491 million (2017)[3]
Total assets	€171.47 million (2017)[4]
Total equity	€129.18 million (2017) [5]
Number of employees	1,070 (2015)
Website	vianex.gr

Vianex S.A. (Greek: Βιανεξ Α.Ε.) is a Greek pharmaceutical company, founded in 1971 by the Giannakopoulos’ family that has been involved with the pharmaceutical industry since 1924.^[6]

The company produces, imports, packages, markets and distributes a large number of pharmaceuticals covering all the various therapeutic classes. It has also formed strategic partnerships and alliances with major pharmaceutical entities across the globe, such as Merck & Co. (U.S.A.), Sanofi Pasteur MSD (France) and Takeda Pharmaceutical Company Limited (Japan). VIANEX S.A. has also been exporting registered products for over 20 years in 35 countries in Europe (UK, France, Spain, Germany, Denmark, Netherlands, Cyprus), the Middle East (Jordan, S. Arabia), Africa (Tunisia, Sudan, South Africa, the Ivory Coast) and Asia (Philippines, Japan, Vietnam, Singapore, Taiwan).^[7]

The headquarters are located in Athens, Greece, while the company owns three factories in the Attica region and one in Patras, Greece.

VIANEX S.A. has also established its own Research & Development department, which undertakes the development of new pharmaceutical formulations for the treatment of various medicinal causes. The company recently began to cooperate with various universities^[who?] on the research and development of new active molecules which are effective in the treatment of serious diseases.^[8]